Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation

被引:36
作者
Ileri, Talia [1 ]
Ertem, Mehmet [1 ]
Ozcakar, Zeynep Birsin [2 ]
Ince, Elif Unal [1 ]
Biyikli, Zeynep [3 ]
Uysal, Zumrut [1 ]
Ekim, Mesiha [2 ]
Yalcinkaya, Fatos [2 ]
机构
[1] Ankara Univ, Sch Med, Dept Pediat Hematol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Biostat, TR-06100 Ankara, Turkey
关键词
acute kidney injury; children; chronic kidney disease; matched related donor; renal function; stem cell transplantation; BONE-MARROW-TRANSPLANTATION; LONG-TERM SURVIVORS; VENOOCCLUSIVE DISEASE; FAILURE; INSUFFICIENCY; INJURY;
D O I
10.1111/j.1399-3046.2009.01182.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Acute and chronic renal impairment are important complications after HSCT. A prospective study was conducted to investigate the glomerular renal function in children who received allogeneic HSCT from matched related donors. Non-radiation conditioning regimens were used in all but one patient. CrCl and serial measurements of serum creatinine were evaluated prior to HSCT, within the first 100 days and one yr after. AKI was defined as at least a 1.5-fold rise in pre-HSCT serum creatinine within the first 100 days and classified as grade 1 to 3 according to the new definition criteria proposed by "AKI Network." Fifty-seven patients were enrolled in the study and 24 patients (42%) had AKI. CsA, amphotericin B, and SOS were found as risk factors for AKI. One yr after HSCT five patients (10%) had CKD and none of them required dialysis. None of the parameters were found as a predictor for CKD. We conclude that AKI is an important complication of HSCT. Careful monitoring of renal function, minimizing the use of nephrotoxic medication, prophylaxis, and effective treatment of SOS might be effective preventive measures to decrease the incidence of AKI.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 26 条
  • [1] Improving outcomes from acute kidney injury: report of an initiative
    Bagga, Arvind
    Bakkaloglu, Aysin
    Devarajan, Prasad
    Mehta, Ravindra L.
    Kellum, John A.
    Shah, Sudhir V.
    Molitoris, Bruce A.
    Ronco, Claudio
    Warnock, David G.
    Joannidis, Michael
    Levin, Adeera
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (10) : 1655 - 1658
  • [2] Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation
    Caliskan, Y.
    Besisik, S. K.
    Sargin, D.
    Ecder, T.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (02) : 141 - 147
  • [3] Cesaro S, 2005, HAEMATOLOGICA, V90, P1396
  • [4] CLINICAL COURSE OF LATE-ONSET BONE-MARROW TRANSPLANT NEPHROPATHY
    COHEN, EP
    LAWTON, CA
    MOULDER, JE
    BECKER, CG
    ASH, RC
    [J]. NEPHRON, 1993, 64 (04) : 626 - 635
  • [5] Defibrotide in the treatment of children with veno-occlusive disease (VOD):: a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
    Corbacioglu, S
    Greil, J
    Peters, C
    Wulffraat, N
    Laws, HJ
    Dilloo, D
    Strahm, B
    Gross-Wieltsch, U
    Sykora, KW
    Ridolfi-Lüthy, A
    Basu, O
    Gruhn, B
    Güngör, T
    Mihatsch, W
    Schulz, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (02) : 189 - 195
  • [6] DAVIS I, 2004, NELSON TXB PEDIAT, P1731
  • [7] Renal function after autologous bone marrow transplantation in children:: a long-term prospective study
    Frisk, P
    Bratteby, LE
    Carlson, K
    Lönnerholm, G
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 (02) : 129 - 136
  • [8] GARAVENTA A, 1992, BONE MARROW TRANSPL, V10, P419
  • [9] CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS
    GLUCKSBERG, H
    STORB, R
    FEFER, A
    BUCKNER, CD
    NEIMAN, PE
    CLIFT, RA
    LERNER, KG
    THOMAS, ED
    [J]. TRANSPLANTATION, 1974, 18 (04) : 295 - 304
  • [10] Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT
    Holthe, JEK
    van Zwet, JML
    Brand, R
    van Weel, MH
    Vossen, JMJJ
    van der Heijden, AJ
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (06) : 559 - 564